Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Talimogene_laherparepvec> ?p ?o }
Showing triples 1 to 97 of
97
with 100 triples per page.
- Talimogene_laherparepvec abstract "Talimogene laherparepvec (tal im' oh jeen la her" pa rep' vek), often simply called "T-VEC" is a cancer-killing (oncolytic) virus currently being studied for the treatment of melanoma and other advanced cancers. The drug was initially developed by BioVex, Inc. under the name OncoVEXGM-CSF until it was acquired by Amgen in 2011.With the announcement of positive results in March 2013, T-VEC is the first oncolytic virus to be proven effective in a Phase III clinical trial.".
- Talimogene_laherparepvec casNumber "1187560-31-1".
- Talimogene_laherparepvec thumbnail Herpes_simplex_virus_TEM_B82-0474_lores.jpg?width=300.
- Talimogene_laherparepvec wikiPageID "38686504".
- Talimogene_laherparepvec wikiPageLength "16028".
- Talimogene_laherparepvec wikiPageOutDegree "40".
- Talimogene_laherparepvec wikiPageRevisionID "682084855".
- Talimogene_laherparepvec wikiPageWikiLink Adaptive_immune_system.
- Talimogene_laherparepvec wikiPageWikiLink Amgen.
- Talimogene_laherparepvec wikiPageWikiLink Antigen.
- Talimogene_laherparepvec wikiPageWikiLink Antigens.
- Talimogene_laherparepvec wikiPageWikiLink Breast_cancer.
- Talimogene_laherparepvec wikiPageWikiLink Category:Amgen.
- Talimogene_laherparepvec wikiPageWikiLink Category:Biotechnology.
- Talimogene_laherparepvec wikiPageWikiLink Category:Experimental_cancer_treatments.
- Talimogene_laherparepvec wikiPageWikiLink Category:Immunomodulating_drugs.
- Talimogene_laherparepvec wikiPageWikiLink Category:Simplexviruses.
- Talimogene_laherparepvec wikiPageWikiLink Category:Virotherapy.
- Talimogene_laherparepvec wikiPageWikiLink Cellulitis.
- Talimogene_laherparepvec wikiPageWikiLink Clinical_trial.
- Talimogene_laherparepvec wikiPageWikiLink Clinical_trials.
- Talimogene_laherparepvec wikiPageWikiLink Colorectal_cancer.
- Talimogene_laherparepvec wikiPageWikiLink Common_Terminology_Criteria_for_Adverse_Events.
- Talimogene_laherparepvec wikiPageWikiLink Common_Toxicity_Criteria.
- Talimogene_laherparepvec wikiPageWikiLink Cytokin.
- Talimogene_laherparepvec wikiPageWikiLink Cytotoxic_T_cell.
- Talimogene_laherparepvec wikiPageWikiLink Dendritic_cell.
- Talimogene_laherparepvec wikiPageWikiLink Dendritic_cells.
- Talimogene_laherparepvec wikiPageWikiLink GM-CSF.
- Talimogene_laherparepvec wikiPageWikiLink Granulocyte_macrophage_colony-stimulating_factor.
- Talimogene_laherparepvec wikiPageWikiLink Head_and_neck_cancer.
- Talimogene_laherparepvec wikiPageWikiLink Herpes_simplex_virus.
- Talimogene_laherparepvec wikiPageWikiLink Herpes_simplex_virus_1.
- Talimogene_laherparepvec wikiPageWikiLink Immune_response.
- Talimogene_laherparepvec wikiPageWikiLink Immune_system.
- Talimogene_laherparepvec wikiPageWikiLink Lysis.
- Talimogene_laherparepvec wikiPageWikiLink Melanoma.
- Talimogene_laherparepvec wikiPageWikiLink Oncolysis.
- Talimogene_laherparepvec wikiPageWikiLink Oncolytic_adenovirus.
- Talimogene_laherparepvec wikiPageWikiLink Oncolytic_herpes_virus.
- Talimogene_laherparepvec wikiPageWikiLink Oncolytic_virus.
- Talimogene_laherparepvec wikiPageWikiLink Pancreatic_cancer.
- Talimogene_laherparepvec wikiPageWikiLink RECIST.
- Talimogene_laherparepvec wikiPageWikiLink Renal_cell_carcinoma.
- Talimogene_laherparepvec wikiPageWikiLink Response_Evaluation_Criteria_in_Solid_Tumors.
- Talimogene_laherparepvec wikiPageWikiLink SCCHN.
- Talimogene_laherparepvec wikiPageWikiLink Virotherapy.
- Talimogene_laherparepvec wikiPageWikiLink Virus.
- Talimogene_laherparepvec wikiPageWikiLink File:Talimogene_laherparepvec_MOA.jpg.
- Talimogene_laherparepvec wikiPageWikiLinkText "Talimogene laherparepvec".
- Talimogene_laherparepvec wikiPageWikiLinkText "talimogene laherparepvec".
- Talimogene_laherparepvec caption "Transmission electron micrograph of an unmodified herpes simplex virus".
- Talimogene_laherparepvec casNumber "1187560".
- Talimogene_laherparepvec chemicalFormula "JS1 34.5-hGMCSF 47- pA-".
- Talimogene_laherparepvec chemspiderid "NA".
- Talimogene_laherparepvec drugName "Talimogene laherparepvec".
- Talimogene_laherparepvec hasPhotoCollection Talimogene_laherparepvec.
- Talimogene_laherparepvec legalStatus "Investigational".
- Talimogene_laherparepvec pregnancyCategory "TBD".
- Talimogene_laherparepvec routesOfAdministration "Injection".
- Talimogene_laherparepvec wikiPageUsesTemplate Template:Clarify.
- Talimogene_laherparepvec wikiPageUsesTemplate Template:Drugbox.
- Talimogene_laherparepvec wikiPageUsesTemplate Template:Reflist.
- Talimogene_laherparepvec wikiPageUsesTemplate Template:Update_after.
- Talimogene_laherparepvec subject Category:Amgen.
- Talimogene_laherparepvec subject Category:Biotechnology.
- Talimogene_laherparepvec subject Category:Experimental_cancer_treatments.
- Talimogene_laherparepvec subject Category:Immunomodulating_drugs.
- Talimogene_laherparepvec subject Category:Simplexviruses.
- Talimogene_laherparepvec subject Category:Virotherapy.
- Talimogene_laherparepvec hypernym Virus.
- Talimogene_laherparepvec type Article.
- Talimogene_laherparepvec type ChemicalSubstance.
- Talimogene_laherparepvec type Company.
- Talimogene_laherparepvec type Drug.
- Talimogene_laherparepvec type Species.
- Talimogene_laherparepvec type Type.
- Talimogene_laherparepvec type Article.
- Talimogene_laherparepvec type Cell.
- Talimogene_laherparepvec type Chemical.
- Talimogene_laherparepvec type Company.
- Talimogene_laherparepvec type Drug.
- Talimogene_laherparepvec type Pediatric.
- Talimogene_laherparepvec type Specialty.
- Talimogene_laherparepvec type Type.
- Talimogene_laherparepvec type ChemicalObject.
- Talimogene_laherparepvec type Thing.
- Talimogene_laherparepvec type Q8386.
- Talimogene_laherparepvec comment "Talimogene laherparepvec (tal im' oh jeen la her" pa rep' vek), often simply called "T-VEC" is a cancer-killing (oncolytic) virus currently being studied for the treatment of melanoma and other advanced cancers. The drug was initially developed by BioVex, Inc. under the name OncoVEXGM-CSF until it was acquired by Amgen in 2011.With the announcement of positive results in March 2013, T-VEC is the first oncolytic virus to be proven effective in a Phase III clinical trial.".
- Talimogene_laherparepvec label "Talimogene laherparepvec".
- Talimogene_laherparepvec sameAs m.0117qddr.
- Talimogene_laherparepvec sameAs Q7679524.
- Talimogene_laherparepvec sameAs Q7679524.
- Talimogene_laherparepvec wasDerivedFrom Talimogene_laherparepvec?oldid=682084855.
- Talimogene_laherparepvec depiction Herpes_simplex_virus_TEM_B82-0474_lores.jpg.
- Talimogene_laherparepvec isPrimaryTopicOf Talimogene_laherparepvec.
- Talimogene_laherparepvec name "Talimogene laherparepvec".